Ozeki A - Search Results

1

Elevated S100A9 in preeclampsia induces soluble endoglin and IL-1β secretion and hypertension via the NLRP3 inflammasome.

Ozeki A, Oogaki Y, Henmi Y, Karasawa T, Takahashi M, Takahashi H, Ohkuchi A, Shirasuna K. Ozeki A, et al. J Hypertens. 2022 Jan 1;40(1):84-93. doi: 10.1097/HJH.0000000000002981. J Hypertens. 2022. PMID: 34412079

2

Preeclamptic patient-derived circulating cell-free DNA activates the production of inflammatory cytokines via toll-like receptor 9 signalling in the human placenta.

Ozeki A, Tani K, Takahashi H, Suzuki H, Nagayama S, Hirashima C, Iwata H, Kuwayama T, Ohkuchi A, Shirasuna K. Ozeki A, et al. J Hypertens. 2019 Dec;37(12):2452-2460. doi: 10.1097/HJH.0000000000002208. J Hypertens. 2019. PMID: 31385869

3

Advanced glycation end products regulate interleukin-1β production in human placenta.

Seno K, Sase S, Ozeki A, Takahashi H, Ohkuchi A, Suzuki H, Matsubara S, Iwata H, Kuwayama T, Shirasuna K. Seno K, et al. Among authors: ozeki a. J Reprod Dev. 2017 Aug 19;63(4):401-408. doi: 10.1262/jrd.2017-032. Epub 2017 May 18. J Reprod Dev. 2017. PMID: 28515391 Free PMC article.

4

A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN).

Morioka T, Takeuchi M, Ozeki A, Emoto M. Morioka T, et al. Among authors: ozeki a. Diabetes Obes Metab. 2024 May 7. doi: 10.1111/dom.15644. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38715179

5

Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.

Takeshima T, Doi H, Ooba S, Tanji Y, Ozeki A, Komori M. Takeshima T, et al. Among authors: ozeki a. Neurol Ther. 2024 Apr 6. doi: 10.1007/s40120-024-00602-z. Online ahead of print. Neurol Ther. 2024. PMID: 38581615

6

Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial.

Komori M, Ozeki A, Tanji Y, Kamiki E, Krege JH, Li LQ, Suzuki S, Shibata M, Takeshima T. Komori M, et al. Among authors: ozeki a. J Headache Pain. 2024 Mar 25;25(1):43. doi: 10.1186/s10194-024-01745-y. J Headache Pain. 2024. PMID: 38528476 Free PMC article. Clinical Trial.

7

Comparison of Analgesic Efficacy and Safety of Low-Dose Transdermal Fentanyl and Oral Oxycodone in Opioid-Naïve Patients with Cancer Pain.

Kawana M, Miyasato A, Funato M, Nagatani K, Suzuki N, Onoda C, Fujimoto H, Ohno R, Kusakabe A, Kiribayashi M, Nakamura K, Kondo M, Ozeki A, Okamoto K, Kokubun H. Kawana M, et al. Among authors: ozeki a. Biol Pharm Bull. 2023;46(10):1444-1450. doi: 10.1248/bpb.b23-00331. Biol Pharm Bull. 2023. PMID: 37779046 Free article.

8

Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial.

Shibata M, Nihira A, Tanji Y, Ozeki A, Imagawa H, Komori M. Shibata M, et al. Among authors: ozeki a. Neurol Ther. 2023 Dec;12(6):2007-2019. doi: 10.1007/s40120-023-00534-0. Epub 2023 Sep 12. Neurol Ther. 2023. PMID: 37698836 Free PMC article.

9

Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms.

Shima Y, Sasagawa S, Ota N, Oyama R, Tanaka M, Kubota-Sakashita M, Kawakami H, Kobayashi M, Takubo N, Ozeki AN, Sun X, Kim YJ, Kamatani Y, Matsuda K, Maejima K, Fujita M, Noda K, Kamiyama H, Tanikawa R, Nagane M, Shibahara J, Tanaka T, Rikitake Y, Mataga N, Takahashi S, Kosaki K, Okano H, Furihata T, Nakaki R, Akimitsu N, Wada Y, Ohtsuka T, Kurihara H, Kamiguchi H, Okabe S, Nakafuku M, Kato T, Nakagawa H, Saito N, Nakatomi H. Shima Y, et al. Among authors: ozeki an. Sci Transl Med. 2023 Jun 14;15(700):eabq7721. doi: 10.1126/scitranslmed.abq7721. Epub 2023 Jun 14. Sci Transl Med. 2023. PMID: 37315111

10

Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study.

Kitamura S, Imai N, Tanji Y, Ozeki A, Komori M. Kitamura S, et al. Among authors: ozeki a. J Pain Res. 2023 May 25;16:1725-1738. doi: 10.2147/JPR.S399567. eCollection 2023. J Pain Res. 2023. PMID: 37255987 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page